Skip to main content
Article thumbnail
Location of Repository

The comparative burden of salmonellosis in the European Union member states, associated and candidate countries

By Birgitta de Jong and Karl Ekdahl
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:1352352
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2005). Andersson Y: Imported giardiasis: impact of international travel, immigration and adoption.
    2. (2005). Andersson Y: The epidemiology of travel-associated shigellosis – regional risks, seasonality and serogroups.
    3. (2001). Antigenic formulas of the Salmonella serovars, 8th revision. WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur,
    4. (1987). B: A phage-typing scheme for Salmonella Enteritidis. Epidem Inf
    5. (2003). Commission: Directive 2003/99/EC of the European Parliament and of the Council of 17
    6. (2003). Commission: Regulation (EC) No 2160/2003 of the European Parliament and of the
    7. (2002). Commission: Trends and sources of zoonotic agents in animals, feedingstuffs, food and man in the European Union and Norway in
    8. (2000). Control of communicable diseases manual. 17th edition. Washington DC: American Public Health Association;
    9. (1998). Ekdahl K: Dengue fever in travellers to the Tropics,
    10. (1990). Foodborne salmonellosis. Lancet
    11. (1995). H: Control of Salmonella Enteritidis in Sweden.
    12. (2002). Health Network and Centre: Illness in England, Wales, and Northern Ireland associated with foreign travel. A baseline report to
    13. (1985). Infective dose of Salmonella typhimurium in cheddar cheese.
    14. (1957). JW: Clinical manifestations of salmonellosis in man: an evaluation of 7779 human infections identified at the New York Salmonella Center.
    15. (1982). LS: A review of human salmonellosis: I. Infective dose. Rev Infect Dis
    16. (1984). MJ: A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis
    17. (1999). PJ: Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ
    18. (2004). Regional risks and seasonality in travelassociated campylobacteriosis.
    19. (1997). Risk factors for sporadic infection with Salmonella Enteritidis,
    20. (1995). Salmonella (including Salmonella typhi).
    21. (2005). Sensitivity of the Swedish statutory surveillance for communicable diseases 1998–2002, assessed by the capture-recapture method. Epidemiol Infect
    22. (1992). SJ: Trends in indigenous foodborne disease and deaths,
    23. (2004). Tauxe RV: FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. CID
    24. (2005). The risk of travel-associated typhoid and paratyphoid fever in various regions of the world.
    25. (2005). Travel-associated non-typhoidal salmonellosis – geographical and seasonal differences and serotype distribution. Clin Microbiol Infect
    26. (2004). Travellers returning to Sweden as sentinels for true disease incidence in other European countries – campylobacter and giardia infection as examples. Euro Surveill
    27. (1990). WHO Surveillance programme for control of foodborne infections and intoxications in Europe, sixth report

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.